AEterna Zentaris to Present at Upcoming BMO Capital Markets 2008 Focus on Healthcare Conference and 28th Annual Canaccord Adams
July 31 2008 - 7:30AM
PR Newswire (US)
QUEBEC CITY, July 31 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (NASDAQ:AEZSNASDAQ:TSX:NASDAQ:AEZ), a global biopharmaceutical
company focused on endocrine therapy and oncology, today announced
that its Senior Vice President and Chief Medical Officer, Paul
Blake, M.D., will present a company overview at the upcoming BMO
Capital Markets 2008 Focus on Healthcare Conference on Tuesday,
August 5, 2008 at 1:45 pm (eastern time), in Room 3 of the
Millennium Broadway Hotel in New York City. Furthermore, Professor,
Jurgen Engel, Ph.D., Executive Vice President and Chief Scientific
Officer at AEterna Zentaris will also present a company overview at
the 28th Annual Canaccord Adams Global Growth Conference on
Wednesday, August 13, 2008 at 10:00 am (Eastern Time) in the London
room of the Intercontinental Hotel in Boston. A live webcast of
Professor Engel's presentation will be available on AEterna
Zentaris' website at http://www.aezsinc.com/ in the Investors
section. A replay will also be available for a period of 30 days on
the Company's website. About AEterna Zentaris Inc. AEterna Zentaris
Inc. is global biopharmaceutical company focused on endocrine
therapy and oncology with proven expertise in drug discovery,
development and commercialization. News releases and additional
information are available at http://www.aezsinc.com/. DATASOURCE:
AETERNA ZENTARIS INC. CONTACT: Investor relations: Dennis Turpin,
CA, Senior Vice President and Chief Financial Officer, (908)
626-5503, ; Media relations: Paul Burroughs, Director of
Communications, (418) 652-8525 ext. 406,
Copyright
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Jul 2023 to Jul 2024